MedTrace Logo

Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases

NCT06541626 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2024-08-07

No results posted yet for this study

Summary

The goal of this observational study is to learn about pathogenesis and clinical prognosis of CNS IIDD in the Chinese population and to provide evidence-based clues for clinical treatment decisions.

The main questions it aims to answer are:

Question 1: Clarify the clinical characteristics and prognostic factors of various diseases (MS, NMOSD, MOGAD, etc.) within IIDD in the Chinese population.

Question 2: Analyze the relationship between biomarkers and the occurrence, progression, and prognosis of CNS IIDD cases in our hospital.

Participants will

1. Receive the recommended diagnosis and treatment plans from current international and national guidelines or expert consensus, without additional special interventions.
2. Receive clinical evaluation, follow-up, and management from dedicated neuroimmunology specialists.

Conditions

  • Multiple Sclerosis, MS
  • Neuromyelitis Optica Spectrum Disorders
  • Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
  • Acute Disseminated Encephalomyelitis
  • Clinically Isolated Syndrome
  • Demyelinating Disorder

Sponsors & Collaborators

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2035-12-31
Completion
2035-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06541626 on ClinicalTrials.gov